 |
CPhI South East Asia
May 10, 2012—May 12, 2012
Jakarta, Indonesia
PDA Chemistry Manufacturing & Controls (CMC) Workshop
May 14, 2012
Bethesda, Maryland
Global Clinical Trials Outsourcing Summit
May 14, 2012–May 15, 2012
Seoul, South Korea
Sixth International Pharmaceutical Compliance Congress
May 14, 2012—May 16, 2012
Budapest, Hungary
PDA FDA Virus and TSE Safety Conference
May 15, 2012—May 17, 2012
Bethesda, Maryland 
|
|
|
 |
Confirm your ePT Weekly subscription
We noticed you haven't opened your ePT Weekly in quite a while. While we don't want to lose you as a valuable reader, we understand that preferences change. If you would like to continue receiving ePT Weekly, please take a moment to confirm your subscription by clicking here.
If you have just been having trouble receiving your ePT Weekly, be sure to add our new email address [email protected] to your address book or safe sender list to ensure delivery.
Thank you,
Pharmaceutical Technology Staff
P.S. You can also use this form to subscribe to other informative e-newsletters from Pharmaceutical Technology – just click here to sign up today! |
|
 |
 |
 Programmable automation controllers provide integrated motion control
A new programmable automation controller (PAC) from Rockwell Automation gives machine builders a high-performance, compact option for integrated motion control. The Allen-Bradley CompactLogix 5370 controllers have increased processing speeds to boost system performance and enhance access to real-time information for improved productivity. User memory ranges from 384KB to 3MB, which makes these controllers ideal for applications such as sorting, labeling and packaging, blending, batching, and filling. The series includes three controllers that support integrated motion: L1 for two axes, L2 for up to four axes, and L3 for up to 16 axes. The series has battery-free energy storage, which, along with other design enhancements and technology developments, allows a more compact size than earlier PAC generations. The PACs are used on a standard EtherNet/IP network that offers more communication bandwidth than available to previous CompactLogix controllers. The controllers use the common design and networking environment of the Rockwell Automation Integrated Architecture system. |
Advertisement:
Brabender® Pharma USA, Inc. is an innovative company specializing in the manufacturing of twin-screw extruders for HME applications. The effort has been to concentrate on the finest quality equipment to produce small batch sizes up to production scale processes. The 12mm Mini-Compounder is ideally suited to this undertaking while other models offer options to achieve production capacity. For further details on the Mini-Compounder  Click Here. |
|
|
 |
Amgen will acquire 95.6% of shares in Mustafa Nevzat Pharmaceuticals (MN), a privately held Turkish pharmaceutical company, for an amount that values MN at $700 million. The all-cash transaction will expand Amgen's presence in Turkey and the surrounding region, which are priority markets for Amgen. Read More
Advertisement:
How-to Video Series: Tablet Press Setup
Get the most from your processing equipment by learning how to properly setup your tablet press. Natoli's newest "how-to" video series demonstrates the correct way to setup your tablet press with step-by-step tooling installation instructions. If you want to get the most from your tablet press and tooling, you can't afford to miss this must-see video series!
 http://www.natoli.com/Press-Setup/Press-Setup-Videos-PT2.html |
AstraZeneca has announced that CEO and Board Member David Brennan has decided to retire, effective June 1, 2012. The board has asked executive director and chief financial officer Simon Lowth to act as interim CEO from June 1 until a permanent successor is in place. Julie Brown, vice-president of the company's group finance division, will become interim chief financial officer on the same date. AstraZeneca also announced today that Leif Johansson will succeed Louis Schweitzer as nonexecutive chairman on June 1—three months earlier than previously announced. Read More
Advertisement:
21 CFR Part 11 Compliance and Business Benefits of Digital Signatures in cGMP Pharmaceutical Manufacturing
Live Webcast: Wednesday, May 9, 2012 at 11:00 AM EDT
Register Free at
 http://www.pharmtech.com/signature |
The United States District Court for the District of New Jersey has ruled in Merck & Co.'s favor in two jointly related patent-infringement lawsuits against Mylan Pharmaceuticals. In its decision, the court upheld Merck’s patent on Zetia (ezetimibe) and Vytorin (ezetimibe; simvastatin) and ruled that the patent was valid and enforceable. The court also issued an injunction blocking the approval of Mylan's generic versions until the expiration of the patent. Mylan had been seeking FDA approval to sell generic versions of Zetia and Vytorin. In December 2009, Merck filed the lawsuit against Mylan regarding Mylan's application to the FDA seeking prepatent expiration approval to sell a generic version of Vytorin. In June 2010, Merck filed a separate lawsuit against Mylan regarding Mylan's application seeking prepatent approval to sell a generic version of Zetia. Read More
Advertisement:
Meeting New Method Transfer Requirements
Live Webcast: May 15, 2012 at 11:00 AM EDT for North America and May 22, 2012 at 11:00 AM CET for Europe
Register Free at  http://www.pharmtech.com/method. |
PRA, a CRO, has reached a new agreement with Amgen for a series of Phase III studies to develop several biosimilar drugs on a worldwide basis. It is intended that PRA will serve as the sole provider of CRO services for these studies. Amgen and PRA signed the agreement in April 2012. Under the new agreement, Amgen and PRA will work together to execute Phase III studies related to Amgen's current biosimilar portfolio. The agreement is intended to govern the entire anticipated scope of Amgen's global biosimilar portfolio. Read More
Advertisement:
Screening Methods for Elemental Impurities: New Regulatory Expectations
Event Date: June 14, 2012 at 11:00 AM EDT for North America and on June 21, 2012 at 11:00 AM CET for Europe.
Register Free at  http://www.pharmtech.com/metals. |
Industry Briefs:
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers. Read More
Do you have news to report on facility expansions, contracts, service agreements, mergers, acquisitions, or personnel appointments? Send press releases to [email protected] |
|
|
 |
|
|
Know Before You Go—2012 Conference Previews
Visit our Show & Exhibition Gateway 2012 to see which companies are exhibiting at upcoming industry conferences.
Find company backgrounders, new product releases, booth materials, and more. Let PharmTech's online
Gateway be your guide to the season's leading shows.
|
|
|
|
|
|
